FB-1603

Febico Biomedical Corp. · Phase 1 active Small molecule

At a glance

Generic name	FB-1603
Sponsor	Febico Biomedical Corp.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss (NA)
To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FB-1603 CI brief — competitive landscape report
FB-1603 updates RSS · CI watch RSS
Febico Biomedical Corp. portfolio CI